Reata Pharmaceuticals, Inc. financial reports, Reata Pharmaceuticals, Inc. annual revenue in 2024. When does Reata Pharmaceuticals, Inc. report revenue?
Reata Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Reata Pharmaceuticals, Inc. revenue for the past few reporting periods. Reata Pharmaceuticals, Inc. net income is now -67 455 000 $. Net income, revenue and dynamics - the main financial indicators of Reata Pharmaceuticals, Inc.. Reata Pharmaceuticals, Inc. online financial report chart. Reata Pharmaceuticals, Inc. financial report on the graph shows the dynamics of assets. The value of the "total revenue of Reata Pharmaceuticals, Inc." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
944 000 $
-87.782 % ↓
-67 455 000 $
-
31/12/2020
3 192 000 $
-59.59 % ↓
-65 776 000 $
-
30/09/2020
1 401 000 $
-82.261 % ↓
-65 456 000 $
-
30/06/2020
3 073 000 $
-60.668 % ↓
-67 581 000 $
-
30/09/2019
7 898 000 $
-
-39 694 000 $
-
30/06/2019
7 813 000 $
-
-34 380 000 $
-
31/03/2019
7 726 000 $
-
-29 154 000 $
-
31/12/2018
7 899 000 $
-
-25 583 000 $
-
30/09/2018
4 766 000 $
-
-30 835 000 $
-
30/06/2018
7 519 000 $
-
-28 211 000 $
-
Show:
to
Reata Pharmaceuticals, Inc. financial report charts
Dates of Reata Pharmaceuticals, Inc. finance reports: 30/06/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Reata Pharmaceuticals, Inc. is available online for such a date - 31/03/2021. Gross profit Reata Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Reata Pharmaceuticals, Inc. is -33 936 000 $
Reata Pharmaceuticals, Inc. quarterly report dates
Cost of revenue Reata Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Reata Pharmaceuticals, Inc. is 34 880 000 $ Total revenue Reata Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Reata Pharmaceuticals, Inc. is 944 000 $ Operating income Reata Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Reata Pharmaceuticals, Inc. is -54 914 000 $
Net income Reata Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Reata Pharmaceuticals, Inc. is -67 455 000 $ Current assets Reata Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Reata Pharmaceuticals, Inc. is 805 520 000 $ Total assets Reata Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Reata Pharmaceuticals, Inc. is 815 084 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-33 936 000 $
-44 268 000 $
-35 782 000 $
-23 711 000 $
-24 381 000 $
-21 741 000 $
-18 388 000 $
-17 410 000 $
-22 378 000 $
-15 910 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
34 880 000 $
47 460 000 $
37 183 000 $
26 784 000 $
32 279 000 $
29 554 000 $
26 114 000 $
25 309 000 $
27 144 000 $
23 429 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
944 000 $
3 192 000 $
1 401 000 $
3 073 000 $
7 898 000 $
7 813 000 $
7 726 000 $
7 899 000 $
4 766 000 $
7 519 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
7 898 000 $
7 813 000 $
7 726 000 $
7 899 000 $
4 766 000 $
7 519 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-54 914 000 $
-63 980 000 $
-54 385 000 $
-40 595 000 $
-38 578 000 $
-33 659 000 $
-28 552 000 $
-24 923 000 $
-29 560 000 $
-26 652 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-67 455 000 $
-65 776 000 $
-65 456 000 $
-67 581 000 $
-39 694 000 $
-34 380 000 $
-29 154 000 $
-25 583 000 $
-30 835 000 $
-28 211 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
97 288 000 $
97 288 000 $
97 288 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
55 858 000 $
67 172 000 $
55 786 000 $
43 668 000 $
46 476 000 $
41 472 000 $
36 278 000 $
32 822 000 $
34 326 000 $
34 171 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
805 520 000 $
847 338 000 $
607 032 000 $
640 467 000 $
246 531 000 $
287 211 000 $
317 472 000 $
342 273 000 $
379 818 000 $
172 412 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
815 084 000 $
857 598 000 $
612 997 000 $
652 404 000 $
259 123 000 $
300 488 000 $
331 285 000 $
345 208 000 $
382 109 000 $
174 719 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
777 624 000 $
818 150 000 $
578 263 000 $
610 419 000 $
240 149 000 $
280 449 000 $
313 056 000 $
337 790 000 $
375 185 000 $
138 676 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
74 562 000 $
67 709 000 $
61 205 000 $
55 920 000 $
62 867 000 $
55 734 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
326 546 000 $
333 961 000 $
335 895 000 $
330 049 000 $
344 564 000 $
342 593 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
126.02 %
111.14 %
101.39 %
95.61 %
90.17 %
196.08 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
369 333 000 $
417 431 000 $
185 844 000 $
231 627 000 $
-67 423 000 $
-33 473 000 $
-4 610 000 $
15 159 000 $
37 545 000 $
-167 874 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-40 335 000 $
-32 709 000 $
-28 732 000 $
-37 497 000 $
3 142 000 $
-25 407 000 $
Last revenue report of Reata Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Reata Pharmaceuticals, Inc. was 944 000 US dollar and changed by -87.782% since last year. Net income in Reata Pharmaceuticals, Inc. was -67 455 000 $ in last quartal, net income changes to 0%.
Current cash Reata Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Reata Pharmaceuticals, Inc. is 777 624 000 $
Reata Pharmaceuticals, Inc. stocks data
RETA stock price
Reata Pharmaceuticals, Inc. stock price today, RETA stock quote.
